These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 2812976)
1. Respiratory syncytial virus infections in children admitted to the intensive care unit. Van Steensel-Moll HA; Van der Voort E; Bos AP; Rothbarth PH; Neijens HJ Pediatrie; 1989; 44(7):583-8. PubMed ID: 2812976 [TBL] [Abstract][Full Text] [Related]
2. [Clinical, therapeutic and developmental aspects of acute bronchiolitis in Tunisia]. Ben Jaballah N; Mnif K; Hedfi L; Hammami A; Khaldi F; Bennaceur B Cah Anesthesiol; 1996; 44(5):423-8. PubMed ID: 9183423 [TBL] [Abstract][Full Text] [Related]
3. Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. The Respiratory Syncytial Virus Immune Globulin Study Group. Groothuis JR; Simoes EA; Levin MJ; Hall CB; Long CE; Rodriguez WJ; Arrobio J; Meissner HC; Fulton DR; Welliver RC N Engl J Med; 1993 Nov; 329(21):1524-30. PubMed ID: 8413475 [TBL] [Abstract][Full Text] [Related]
4. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. The IMpact-RSV Study Group. Pediatrics; 1998 Sep; 102(3 Pt 1):531-7. PubMed ID: 9738173 [TBL] [Abstract][Full Text] [Related]
5. The severity of respiratory syncytial virus bronchiolitis in young infants in the United Arab Emirates. Howidi M; Rajah J; Abushrar Z; Parsons H J Trop Pediatr; 2007 Feb; 53(1):22-6. PubMed ID: 17008442 [TBL] [Abstract][Full Text] [Related]
6. Respiratory syncytial virus infection in children with bronchopulmonary dysplasia. Groothuis JR; Gutierrez KM; Lauer BA Pediatrics; 1988 Aug; 82(2):199-203. PubMed ID: 3399292 [TBL] [Abstract][Full Text] [Related]
8. Management of severe bronchiolitis: indications for ventilator support. Gavin R; Anderson B; Percival T N Z Med J; 1996 Apr; 109(1020):137-9. PubMed ID: 8649668 [TBL] [Abstract][Full Text] [Related]
9. Impact of severe disease caused by respiratory syncytial virus in children living in developed countries. Simoes EA; Carbonell-Estrany X Pediatr Infect Dis J; 2003 Feb; 22(2 Suppl):S13-8; discussion S18-20. PubMed ID: 12671448 [TBL] [Abstract][Full Text] [Related]
10. Prediction of the duration of hospitalization in patients with respiratory syncytial virus infection: use of clinical parameters. McMillan JA; Tristram DA; Weiner LB; Higgins AP; Sandstrom C; Brandon R Pediatrics; 1988 Jan; 81(1):22-6. PubMed ID: 3336593 [TBL] [Abstract][Full Text] [Related]
11. [Respiratory insufficiency in acute bronchiolitis in infancy]. Grubbauer HM; Haim M; Zach M; Zobel G Pneumologie; 1989 Jun; 43(6):295-8. PubMed ID: 2755928 [TBL] [Abstract][Full Text] [Related]
12. Pre-existing disease is associated with a significantly higher risk of death in severe respiratory syncytial virus infection. Thorburn K Arch Dis Child; 2009 Feb; 94(2):99-103. PubMed ID: 18653625 [TBL] [Abstract][Full Text] [Related]
13. Variables explaining the duration of hospitalization in children under two years of age admitted with acute airway infections: does respiratory syncytial virus have a direct impact? Weigl JA; Puppe W; Schmitt HJ Klin Padiatr; 2004; 216(1):7-15. PubMed ID: 14747964 [TBL] [Abstract][Full Text] [Related]
14. [Pathogen role of coronavirus in pediatric intensive care: retrospective analysis of 19 positive samples with indirect immunofluorescence]. Sizun J; Soupre D; Legrand MC; Giroux JD; Rubio S; Chastel C; Alix D; de Parscau L Arch Pediatr; 1994 May; 1(5):477-80. PubMed ID: 7951832 [TBL] [Abstract][Full Text] [Related]
15. Paediatric intensive care admissions for respiratory syncytial virus bronchiolitis in France: results of a retrospective survey and evaluation of the validity of a medical information system programme. Soilly AL; Ferdynus C; Desplanches O; Grimaldi M; Gouyon JB Epidemiol Infect; 2012 Apr; 140(4):608-16. PubMed ID: 21733254 [TBL] [Abstract][Full Text] [Related]
16. Prophylaxis in RSV infection (Palivizumab)--is it worthwhile? Hashmi NA; Cosgrove JF; MacMahon P Ir Med J; 2000 Dec; 93(9):284. PubMed ID: 11209917 [TBL] [Abstract][Full Text] [Related]
17. Intravenous palivizumab and ribavirin combination for respiratory syncytial virus disease in high-risk pediatric patients. Chávez-Bueno S; Mejías A; Merryman RA; Ahmad N; Jafri HS; Ramilo O Pediatr Infect Dis J; 2007 Dec; 26(12):1089-93. PubMed ID: 18043443 [TBL] [Abstract][Full Text] [Related]
18. RSV outbreak in a paediatric intensive care unit. Thorburn K; Kerr S; Taylor N; van Saene HK J Hosp Infect; 2004 Jul; 57(3):194-201. PubMed ID: 15236847 [TBL] [Abstract][Full Text] [Related]
19. The need for inotropic support in a subgroup of infants with severe life-threatening respiratory syncytial viral infection. Kim KK; Frankel LR J Investig Med; 1997 Oct; 45(8):469-73. PubMed ID: 9394100 [TBL] [Abstract][Full Text] [Related]
20. Severity of respiratory syncytial virus bronchiolitis is affected by cigarette smoke exposure and atopy. Bradley JP; Bacharier LB; Bonfiglio J; Schechtman KB; Strunk R; Storch G; Castro M Pediatrics; 2005 Jan; 115(1):e7-14. PubMed ID: 15629968 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]